Summary for ๐
-Commends congress on Bipartisan legistative action aimed at bolstering U.S bio-manufacturing.
-CEO bought 2.5million shares upon offerings.
-Two giant gaps.
-570% Revenue reported last month.
-Recently regained compliance
-Achieved major milestone with cGmp facility validation for Microbial Manufacturing.
A good to watch next week.
Come join us
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
FattyChickOP : You guys are welcome.